Compounded semaglutide vs brand name Wegovy: what is the real difference?

Short answer

• Wegovy is the FDA‑approved, brand‑manufactured semaglutide product that was tested in large randomized trials for weight loss and is made under pharmaceutical‑grade manufacturing and sterility controls.
• “Compounded semaglutide” is made by compounding pharmacies (or outsourcing facilities) from bulk API or by re‑packaging, and it is not FDA‑approved as a finished product for weight loss — quality, potency, sterility, excipients, and stability can vary. That means differences in safety, reliability, and evidence.

Key differences (what matters in practice)

1. Regulatory status and evidence

   • Wegovy (Novo Nordisk) is FDA‑approved for chronic weight management after large STEP trials demonstrating safety and efficacy at the 2.4 mg weekly dose. Its labeling, dosing, and adverse-event profile are known.
   • Compounded semaglutide does not have FDA approval as a finished drug for weight loss and has not been tested in the same large, controlled trials. Efficacy and safety claims depend on limited, variable data.

2. Manufacturing quality, purity and sterility

   • Wegovy is produced under strict pharmaceutical manufacturing standards (good manufacturing practices, batch control, validated stability).
   • Compounded products are made by pharmacies that are regulated differently (state boards for 503A compounding pharmacies; 503B outsourcing facilities have some FDA oversight). The source of the active ingredient, testing for impurities, sterility validation, and stability can differ from one compounder to another. This raises small but real risks of variability or contamination.

3. Formulation, excipients and device

   • Wegovy comes as a prefilled pen with a validated formulation and known stability/shelf life for refrigerated and room‑temperature periods.
   • Compounded semaglutide may be supplied as vials, syringes, or alternative pens and may use different excipients, which can change stability, injection pain, or absorption.

4. Dosing and labeling

   • Wegovy has an approved titration schedule and clear labeling for side effects and monitoring.
   • Compounded doses and titration may be variable; if a compounder supplies incorrect concentration or labels incorrectly, dosing errors can occur.

5. Cost and access

   • Wegovy can be expensive and often not covered by insurance. Novo Nordisk offers savings programs that can help eligible patients.
   • Compounded semaglutide is often cheaper, which is why many people seek it — but the lower price comes with tradeoffs in assurance of quality and evidence.

6. Pharmacovigilance and recall

   • Adverse events and quality issues with Wegovy are tracked through established reporting and recall systems.
   • Problems with compounded drugs may be harder to trace and may not prompt voluntary recall as quickly.

If you’re considering compounded semaglutide — what to ask and check

• Is the pharmacy PCAB‑accredited or an FDA‑registered 503B outsourcing facility? (these have higher oversight)
• Where does the raw semaglutide API come from? Do they provide a Certificate of Analysis (CoA) showing identity, potency, and impurity testing?
• Do they perform sterility and endotoxin testing for each batch?
• What is the exact concentration, recommended dosing/titration, and how is it labeled?
• What packaging and delivery device will you get (prefilled pen vs vial/syringe), and what are storage instructions?
• What expiry dating and lot tracking do they provide?
• Will your prescriber oversee monitoring for adverse effects (pancreatitis risk, gallbladder issues, blood sugar changes, thyroid nodules in certain animals — discuss human thyroid medullary carcinoma risk in family history, etc.)?

Bottom line / recommendation

• If you want the safest option backed by clinical trials and consistent manufacturing, choose Wegovy and discuss cost‑assistance options with your provider or the manufacturer’s program.
• If cost is prohibitive and you consider compounded semaglutide, use a reputable, accredited compounder, have careful clinical follow‑up with your prescriber, and get documentation on source, testing, and sterility. Be aware you’re accepting more uncertainty about product quality and evidence.

If you want, I can:

• Compare Wegovy vs Ozempic (both are semaglutide but different doses/indications) or vs tirzepatide (Mounjaro/Zepbound) for weight treatment.
• Provide a short checklist you can give to a compounding pharmacy or your prescriber.